Spravato (Esketamine)

A break­through med­ica­tion treat­ment for treat­ment-resis­tant depres­sion and for the rapid reduc­tion in symp­toms with major depres­sive dis­or­der with acute sui­ci­dal thoughts or behavior.

SPRA­VA­TO® is the only FDA-approved nasal spray for adults with treat­ment-resis­tant depres­sion that can be tak­en with or with­out an oral anti­de­pres­sant, giv­ing you more options and flexibility.

• SPRA­VA­TO® reduces depres­sion symp­toms when oral anti­de­pres­sants haven’t worked
• SPRA­VA­TO® works dif­fer­ent­ly by act­ing on glutamate
• Glu­ta­mate is a chem­i­cal mes­sen­ger found in the brain that is thought to help bal­ance well-being and depression
• The exact way SPRA­VA­TO® works is unknown

What is SPRA­VA­TO® (eske­t­a­mine) CIII nasal spray?
SPRA­VA­TO® is a pre­scrip­tion med­i­cine used:

• with or with­out an anti­de­pres­sant tak­en by mouth, to treat adults with treat­ment-resis­tant depres­sion (TRD)
• with an anti­de­pres­sant tak­en by mouth, to treat depres­sive symp­toms in adults with major depres­sive dis­or­der (MDD) with sui­ci­dal thoughts or actions SPRA­VA­TO® is not for use as a med­i­cine to pre­vent or relieve pain (anes­thet­ic).
• It is not known if SPRA­VA­TO® is safe or effec­tive as an anes­thet­ic medicine.
• It is not known if SPRA­VA­TO® is safe and effec­tive for use in pre­vent­ing sui­cide or in reduc­ing sui­ci­dal thoughts or actions. SPRA­VA­TO® is not for use in place of hos­pi­tal­iza­tion if your health­care provider deter­mines that hos­pi­tal­iza­tion is need­ed, even if improve­ment is expe­ri­enced after the first dose of SPRAVATO®.
• It is not known if SPRA­VA­TO® is safe and effec­tive in children.

For more infor­ma­tion about Spra­va­to, please vis­it: https://​www​.spra​va​to​.com/

To sched­ule an appoint­ment, please call 815−942−6323 or sched­ule through MyChart.